No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In
(MedPage Today) -- AMSTERDAM -- Two trials from Asia weighed in on reducing components and duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) but with questionable applicability to Western practice.
Both...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Angioplasty | Aspirin | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention